Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues

Dong Joon Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(2):115-122. Published online May 2, 2017

DOI: https://doi.org/10.3350/cmh.2017.0018

View: 8929 Download: 228 Web of Science: 12 Crossref: 14

Original Article

Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure

Jung Min Ha, Won Sohn, Ju Yeon Cho, Jeung Hui Pyo, Kyu Choi, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Chul Koh, Seung Woon Paik, Byung Chul Yoo, Yong-Han Paik

Clin Mol Hepatol. 2015;21(3):232-241. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.232

View: 7628 Download: 89 Web of Science: 7 Crossref: 7

The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites

Jun Jae Kim, Jeong Han Kim, Ja Kyung Koo, Yun Jung Choi, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2014;20(1):47-55. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.47

View: 6108 Download: 47 Web of Science: 5 Crossref: 2

3

Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated Liver cirrhosis

Sung Hoa Lee, M.D., Seung Ha Park, M.D., Go Woon Kim, M.D., Woo Jin Lee, M.D., Won Ki Hong, M.D., Myeong Shin Ryu, M.D., Kyu Tae Park, M.D., Min Young Lee, M.D., Chan Woo Lee, M.D., Jin Ho Kim, M.D., Yong Mook Kim, M.D., Sung Jung Kim, M.D., Gwang Ho Baik, M.D., Jin Bong Kim, M.D., Dong Joon Kim, M.D.

Clin Mol Hepatol. 2009;15(3):350-356. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.350

View: 5148 Download: 30 Crossref: 3

1 |

Viewed By 5181	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5041	MAFLD: How is it different from NAFLD?
Viewed By 4996	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3677	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3635	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search